Dr Noah Collins, PHD | |
University Of Maryland Counseling Ctr, Shoemaker Building - Room 1133, College Park, MD 20742-0001 | |
(301) 314-7661 | |
Not Available |
Full Name | Dr Noah Collins |
---|---|
Gender | Male |
Speciality | Psychologist - Counseling |
Location | University Of Maryland Counseling Ctr, College Park, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003224494 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | 4639 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Noah Collins, PHD University Of Maryland Counseling Ctr, Shoemaker Building - Room 1133, College Park, MD 20742-0001 Ph: (301) 314-7661 | Dr Noah Collins, PHD University Of Maryland Counseling Ctr, Shoemaker Building - Room 1133, College Park, MD 20742-0001 Ph: (301) 314-7661 |
News Archive
Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone, according to a study published in the March edition of the Annals of the Rheumatic Diseases.
The patient-centered medical home (PCMH) model is an emerging team-based approach for primary health care. PCMH is aimed at improving timely access to care, providing continuity of care by a health care team and lowering health care costs. PCMH aims to alleviate future health problems through tailored health care that focuses on patient wellness and prevention.
More than 70 leading medical specialists, nurses, patient advocates, researchers, regulatory / Health Technology Assessment experts and industry representatives gathered on 3 May 2017 in Valencia, Spain to discuss existing challenges and what is needed to improve the situation of patients affected by myelodysplastic syndromes (MDS).
Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
› Verified 9 days ago
Dr. Myra Waters, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 9658 Baltimore Ave, #240, College Park, MD 20740 Phone: 443-824-2815 | |
Dr. Pepper Ellen Phillips, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1122 Shoemaker Bldg, University Of Maryland, College Park, MD 20742 Phone: 301-314-7672 Fax: 301-314-9206 | |
Melissa Dawn Latham, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4094 Campus Dr Bps 2114, College Park, MD 20742 Phone: 916-208-4010 | |
Christopher Jonathan Seitz-brown, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9729 51st Pl, College Park, MD 20740 Phone: 717-817-3049 | |
Dr. John Zager, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4700 Berwyn House Rd, Suite 105, College Park, MD 20740 Phone: 301-537-7284 Fax: 301-474-0432 | |
Dr. Theodore Pickett Jr., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4281 Chapel Lane, College Park, MD 20742 Phone: 301-314-7667 |